Dynamic Technology Lab Private LTD Abb Vie Inc. Transaction History

Dynamic Technology Lab Private LTD

$914 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $278,267 - $322,135	-2,083 Reduced 19.94%	8,364 $1.25 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1.38 Million - $1.72 Million	10,447 New	10,447 $1.41 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $240,467 - $298,352	-1,822 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $195,737 - $247,664	1,822 New	1,822 $247,000
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $563,813 - $640,013	-5,299 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $557,507 - $621,095	5,299 New	5,299 $597,000
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $422,974 - $571,060	-5,255 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $451,457 - $529,861	5,255 New	5,255 $460,000
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $399,900 - $606,298	-6,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $447,206 - $559,550	6,200 New	6,200 $549,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $584,328 - $702,530	-9,278 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $147,299 - $188,283	2,242 Added 31.86%	9,278 $675,000
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $542,757 - $638,798	7,036 New	7,036 $567,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.16 Million - $1.29 Million	-13,095 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $753,703 - $891,800	8,395 Added 178.62%	13,095 $1.21 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $432,447 - $579,087	4,700 New	4,700 $445,000
Q3 2017 Nov 08, 2017	SELL	$69.85 - $89.22 $265,430 - $339,036	-3,800 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	3,800	3,800 $276,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Account